Literature DB >> 24867514

S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.

W Zhang1, Y Liu, C-w Wang.   

Abstract

OBJECTIVE: S100A4 is a member of the S100 family of calcium-binding proteins, which possesses a wide range of biological functions, such as regulation of angiogenesis, cell survival, motility, and invasion. Here, we demonstrate for the first time a major role of S100A4 in the cell invasion properties of the human laryngeal squamous carcinoma cells (LSCC) and evaluated the mechanism.
MATERIALS AND METHODS: Cultured human LSCC cell line Hep-2 was overexpressed by transfection of pcDNA3.1-S100A4 plasmid. For this, cellular Hep-2 expression was quantified by Western blot analysis. Moreover, cell invasion and migration assays were performed. Furthermore, the impact of the S100A4 on NF-kB activity and MMP-9 expression was detected.
RESULTS: We found S100A4 potently promoted Hep-2 invasion, by increasing cell motility and matrix metalloproteinase-9 (MMP-9) production. The increase in MMP-9 production was mediated by activation of nuclear factor-kB transcriptional activity by S100A4. After MMP-9 and NF-kBp65 was inhibited by BB94 treatment and NF-kBp65 siRNA transfected, pcDNA3.1-S100A4 induced cell invasion and migration was decreased.
CONCLUSIONS: Our findings thus establish S100A4 as a major factor in the invasive abilities of Hep-2 cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867514

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway.

Authors:  Kai Zhang; Jing Chen; Dongqin Chen; Jiayuan Huang; Bing Feng; Siqi Han; Yitian Chen; Haizhu Song; Wei De; Ziman Zhu; Rui Wang; Longbang Chen
Journal:  Oncotarget       Date:  2014-12-30

2.  MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.

Authors:  John Zeng-Hong Li; Wei Gao; Wen-Bin Lei; Jing Zhao; Jimmy Yu-Wai Chan; William Ignace Wei; Wei-Kuen Ho; Thian-Sze Wong
Journal:  Oncotarget       Date:  2016-09-06

Review 3.  Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.

Authors:  Camila Hernandes; Ana Maria Soares Pereira; Patricia Severino
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

Review 4.  Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.

Authors:  Manny D Bacolod; Swadesh K Das; Upneet K Sokhi; Steven Bradley; David A Fenstermacher; Maurizio Pellecchia; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2015-05-23       Impact factor: 6.242

5.  Increased expression levels of S100A4 associated with hypoxia-induced invasion and metastasis in esophageal squamous cell cancer.

Authors:  Xiaoyan Xuan; Qianru Li; Zhongning Zhang; Ying Du; Pingping Liu
Journal:  Tumour Biol       Date:  2014-09-13

6.  Orf Virus 002 Protein Targets Ovine Protein S100A4 and Inhibits NF-κB Signaling.

Authors:  Daxiang Chen; Zewei Zheng; Bin Xiao; Wei Li; Mingjian Long; Huiqin Chen; Ming Li; Daniel L Rock; Wenbo Hao; Shuhong Luo
Journal:  Front Microbiol       Date:  2016-09-13       Impact factor: 5.640

7.  A link between RelB expression and tumor progression in laryngeal cancer.

Authors:  Ioanna Giopanou; Ioannis Lilis; Helen Papadaki; Theodoros Papadas; Georgios T Stathopoulos
Journal:  Oncotarget       Date:  2017-12-09

8.  Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation.

Authors:  Zeqian Yu; Susu Zhao; Long Ren; Lishan Wang; Zhangjun Chen; Robert M Hoffman; Jiahua Zhou
Journal:  Oncotarget       Date:  2017-06-28

9.  Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles.

Authors:  Hisako Ibaraki; Takanori Kanazawa; Minami Owada; Keiko Iwaya; Yuuki Takashima; Yasuo Seta
Journal:  Pharmaceutics       Date:  2020-01-15       Impact factor: 6.321

10.  SiRNA-Mediated RRM2 Gene Silencing Combined with Cisplatin in the Treatment of Epithelial Ovarian Cancer In Vivo: An Experimental Study of Nude Mice.

Authors:  Ting Xue; Liming Wang; Yong Li; Hao Song; Huijun Chu; Hongjuan Yang; Ailian Guo; Jinwen Jiao
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.